Razobazam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401547This classification denotes a sedative, hypnotic, and anxiolytic with the molecular formula C14H14N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LZ84VWN0U4, chemically known as 4,8-dihydro-3,8-dimethyl-4-phenylpyrazolo(3,4-b)(1,4)diazepine-5,7(1h,6h)-dione but generally known as razobazam, which bears US NIH Compound Identifier 71228. European Medicines Agency schedules Razobazam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10265MIG. The term RAZOBAZAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). RAZOBAZAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule razobazam under HS 29337900 and SITC 51561. As of Q4 2014, RAZOBAZAM remains the US FDA Preferred Term for this commodity. Razobazam bears US NLM identifiers UMLS ID C2347895 and NCI Concept Code C73211. SMILES: O=C1N(C2C(N(C(=O)C1)C)N[NH]C2C)C1CCCCC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.